INDALO THERAPEUTICS, INC.

Profile

Company Names

INDALO THERAPEUTICS, INC.
ANTEGRIN THERAPEUTICS, INC.

Addresses

4320 FOREST PARK AVENUE, SUITE 304, ST. LOUIS, MO 63108

4320 FOREST PARK AVENUE, SUITE 303, ST. LOUIS, MO 63108

Phone Numbers

314-932-4032
314-932-4032 X317

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2014

State Incorporated:

DELAWARE

Total Amount Raised:

$9,695,614.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2017-06-30 
$8,999,996.00 
$25,999,992.00 
$16,999,996.00 
Equity 
2
2015-09-17 
$100,000.00 
$600,000.00 
$500,000.00 
Equity 
1
2014-12-31 
$595,618.00 
$595,618.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GEORGE 
H. 
CAPPS II 
EXECUTIVE OFFICER, PROMOTER
GEORGE 
H. 
CAPPS, II 
EXECUTIVE OFFICER
THOMAS 
P. 
CIRRITO 
DIRECTOR
DAVID 
W. 
GRIGGS 
DIRECTOR
ROBERT 
W. 
KARR 
EXECUTIVE OFFICER, DIRECTOR
SCOTT 
 
SEIWERT 
EXECUTIVE OFFICER
BRADFORD 
 
WILLIAMSON 
EXECUTIVE OFFICER
MICHAEL 
 
YEADON 
DIRECTOR
MICHAEL 
A. 
YEADON 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-06-30 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-31 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#